Related references
Note: Only part of the references are listed.COVID-19 associated with pulmonary aspergillosis: A literature review
Chih-Cheng Lai et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)
Burden of serious fungal infections in the Netherlands
Jochem B. Buil et al.
MYCOSES (2020)
Azole-ResistantAspergillus fumigatusAmong Danish Cystic Fibrosis Patients: Increasing Prevalence and Dominance of TR34/L98H
Malene Risum et al.
FRONTIERS IN MICROBIOLOGY (2020)
In Vitro Interaction between Isavuconazole and Tacrolimus, Cyclosporin A, or Sirolimus againstAspergillusSpecies
Patrick Schwarz et al.
JOURNAL OF FUNGI (2020)
Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China
LiLi Zhang et al.
MYCOPATHOLOGIA (2020)
In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosis
Saeed Mahdavi Omran et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs
Jochem B. Buil et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
In vitro antifungal activity of amphotericin B and 11 comparators against Aspergillus terreus species complex
Afsane Vaezi et al.
MYCOSES (2018)
Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity
J. Denis et al.
JOURNAL DE MYCOLOGIE MEDICALE (2018)
Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?
Tamara Zoran et al.
FRONTIERS IN MICROBIOLOGY (2018)
Aspergillus Species and Antifungals Susceptibility in Clinical Setting in the North of Portugal: Cryptic Species and Emerging Azoles Resistance in A-fumigatus
Eugenia Pinto et al.
FRONTIERS IN MICROBIOLOGY (2018)
Luliconazole, an alternative antifungal agent against Aspergillus terreus
M. Zargaran et al.
JOURNAL DE MYCOLOGIE MEDICALE (2017)
Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard
Shawn R. Lockhart et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Mojtaba Nabili et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Clinical implications of globally emerging azole resistance in Aspergillus fumigatus
Jacques F. Meis et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2016)
PCR-RFLP on β-tubulin gene for rapid identification of the most clinically important species of Aspergillus
Tuba Nasri et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2015)
Azole-resistant Aspergillus fumigatus isolates carrying TR34/L98H mutations in Taiwan
Chi-Jung Wu et al.
MYCOSES (2015)
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases
O. A. Cornely et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Cryptic and Rare Aspergillus Species in Brazil: Prevalence in Clinical Samples and In Vitro Susceptibility to Triazoles
C. E. Negri et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution Method
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus
Eveline Snelders et al.
PLOS ONE (2012)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B and Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection
Susan Julie Howard et al.
MEDICAL MYCOLOGY (2011)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)
A. Espinel-Ingroff et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Molecular Identification of Aspergillus Species Collected for the Transplant-Associated Infection Surveillance Network
S. Arunmozhi Balajee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Molecular diagnosis of Aspergillus endocarditis after cardiac surgery
Parisa Badiee et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure
Susan J. Howard et al.
EMERGING INFECTIOUS DISEASES (2009)
Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Eveline Snelders et al.
PLOS MEDICINE (2008)
Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area
Jesus Guinea et al.
MEDICAL MYCOLOGY (2006)
Epidemiology and outcome of infections due to Aspergillus terreus:: 10-year single centre experience
C Lass-Flörl et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Share Paper
